At $300M Kardigan startup, former MyoKardia team unveils its first drug, and it comes from Ionisnews2025-03-07T16:16:52+00:00March 7th, 2025|Endpoints News|
J&J axes Phase 3 depression program due to ‘insufficient efficacy’ shortly after Neumora’s study failnews2025-03-07T09:43:21+00:00March 7th, 2025|Endpoints News|
Moderna stands by its Covid vaccine patents after PTAB decisionnews2025-03-06T19:52:02+00:00March 6th, 2025|Endpoints News|
Merck KGaA says earlier moves to localize manufacturing help ease Trump tariff impact news2025-03-06T15:26:35+00:00March 6th, 2025|Endpoints News|
Makary hearing updates: Trump FDA nominee faces Senatenews2025-03-06T14:00:08+00:00March 6th, 2025|Endpoints News|
No news is good news? Merck KGaA quiet on potential SpringWorks takeovernews2025-03-06T11:58:31+00:00March 6th, 2025|Endpoints News|
Judge grants new nationwide block on NIH payment cuts news2025-03-05T20:52:17+00:00March 5th, 2025|Endpoints News|
Bavarian Nordic CEO says reshoring manufacturing to the US can take yearsnews2025-03-05T18:30:12+00:00March 5th, 2025|Endpoints News|
Novo Nordisk slashes Wegovy price for patients without insurance news2025-03-05T16:52:07+00:00March 5th, 2025|Endpoints News|
Bhattacharya hearing updates: Trump NIH nominee faces Senatenews2025-03-05T14:00:45+00:00March 5th, 2025|Endpoints News|
